Illinois Hospital Report Card

and Consumer Guide to Health Care

OSF St. Joseph Medical Center

Patient Safety - CDI & MRSA

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Facility-wide Healthcare Facility Onset Incidence Rates for CDI and MRSA are presented below. These rates are based on results of laboratory tests that were obtained on or after day four of an inpatient stay and do not consider presence or timing of clinical signs or symptoms. The Standardized Infection Ratio (SIR) is presented, which is a summary measure used to determine if rates of CDI and MRSA bloodstream infections are statistically different from the national average. Statewide summaries of CDI and MRSA data arranged by hospital are also included. Note: Starting with 2016 data, new methods for risk adjustment were used.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
114	Complete Reporting: Number of predicted events too low to calculate a precise SIR
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted

Healthcare Facility Onset Incidence Rate	Result	SIR
Methicillin-resistant Staphylococcus aureus (MRSA) blood stream infections Q1 2023 - Q4 2023 Result 1 infections, 37956 patient days Rating SIR: 0.61	1 infections, 37956 patient days	0.61
Description Methicillin-resistant Staphylococcus aureus infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 1 infections, 39067 patient days Rating SIR: 0.48	1 infections, 39067 patient days	0.48
Q1 2021 - Q4 2021 Result 1 infections, 39394 patient days Rating SIR: 0.50	1 infections, 39394 patient days	0.50
Q1 2020 - Q4 2020 Result 2 infections, 32971 patient days Rating SIR: 1.19	2 infections, 32971 patient days	1.19
Q1 2019 - Q4 2019 Result 2 infections, 34449 patient days Rating SIR: 1.04	2 infections, 34449 patient days	1.04
Q1 2018 - Q4 2018 Result 0 infections, 32640 patient days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 32640 patient days ¹¹⁷	0.00 ¹¹⁷
Q1 2017 - Q4 2017 Result 0 infections, 31080 patient days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 31080 patient days ¹¹⁷	0.00 ¹¹⁷
Q1 2016 - Q4 2016 Result 0 infections, 26357 patient days ¹¹⁴ Rating SIR: N/A ¹¹⁴	0 infections, 26357 patient days ¹¹⁴	N/A ¹¹⁴
Q1 2015 - Q4 2015 Result 1 infections, 25645 patient days Rating SIR: 0.93	1 infections, 25645 patient days	0.93
Q1 2014 - Q4 2014 Result 2 infections, 25873 patient days Rating SIR: 1.93	2 infections, 25873 patient days	1.93
Q1 2013 - Q4 2013 Result 1 infections, 25744 patient days Rating SIR: 0.90	1 infections, 25744 patient days	0.90
Q1 2012 - Q4 2012 Result 0 infections, 26117 patient days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 26117 patient days ¹¹⁷	0.00 ¹¹⁷
Q1 2012 - Q2 2012 Result 0 infections, 13422 patient days Rating SIR: 0.00	0 infections, 13422 patient days	0.00
Clostridioides difficile infections (CDI) Q1 2023 - Q4 2023 Result 3 infections, 36436 patient days Rating SIR: 0.22	3 infections, 36436 patient days	0.22
Description Clostridium difficile infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 7 infections, 37706 patient days Rating SIR: 0.35	7 infections, 37706 patient days	0.35
Q1 2021 - Q4 2021 Result 29 infections, 37675 patient days Rating SIR: 1.37	29 infections, 37675 patient days	1.37
Q1 2020 - Q4 2020 Result 20 infections, 31391 patient days Rating SIR: 1.19	20 infections, 31391 patient days	1.19
Q1 2019 - Q4 2019 Result 19 infections, 32579 patient days Rating SIR: 1.04	19 infections, 32579 patient days	1.04
Q1 2018 - Q4 2018 Result 20 infections, 31226 patient days Rating SIR: 1.02	20 infections, 31226 patient days	1.02
Q1 2017 - Q4 2017 Result 27 infections, 29512 patient days Rating SIR: 1.83	27 infections, 29512 patient days	1.83
Q1 2016 - Q4 2016 Result 20 infections, 26357 patient days Rating SIR: 1.59	20 infections, 26357 patient days	1.59
Q1 2015 - Q4 2015 Result 8 infections, 25645 patient days Rating SIR: 0.65	8 infections, 25645 patient days	0.65
Q1 2014 - Q4 2014 Result 10 infections, 25873 patient days Rating SIR: 0.79	10 infections, 25873 patient days	0.79
Q1 2013 - Q4 2013 Result 19 infections, 25744 patient days Rating SIR: 1.52	19 infections, 25744 patient days	1.52
Q1 2012 - Q4 2012 Result 15 infections, 26117 patient days Rating SIR: 1.07	15 infections, 26117 patient days	1.07